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appropriate and accessible level of readability. Eight consumer health information 
websites were selected and a portion of text from each on the topic of macular 
degeneration, an eye disease that affects many older Americans and can result in the loss 
of central vision, was evaluated. The readability of the text was calculated using two 
tests: the Flesch-Kincaid Grade Level Index and the Flesch Reading Ease test. These 
calculations confirmed expectations that online consumer health information for macular 
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I. Introduction 
As consumers search for an increasing amount of health information online, it is 
important for the information that they find to not only be accurate, but written in an 
appropriate and accessible level of readability. According to the National Adult Literacy 
Survey, the average American adult reads at the seventh grade level, but more than half 
of the population of the country reads below the sixth grade level (DuBay 1). Experts 
have recommended that information about health should be written at a fifth grade level 
(DuBay 1). But is this the case with online consumer health information?  
 For this study, eight consumer health information websites were selected and a 
portion of text from each on the topic of macular degeneration, an eye disease that affects 
many older Americans, was evaluated. The readability of the text was calculated using 
two tests: the Flesch-Kincaid Grade Level Index and the Flesch Reading Ease test. The 
Flesch-Kincaid Grade Level Index test calculates the American grade level of written 
material (DuBay 26). It is one of the most popular reading ability calculators used today 
and is currently used by the Department of Defense, the Social Services Administration, 
and the Internal Revenue Service to calculate the readability of their published materials 
(DuBay 31, 54). The Flesch Reading Ease Score calculates the difficulty of reading 
material on a scale of one to one hundred, with a score of one hundred indicating a very 
easy level of readability, scores between sixty and seventy to be a “standard” reading 
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level, and scores between zero and thirty to be at a college graduate level (DuBay 21-22). 
The goal of this research was to find answers to the following research questions: 
1. What is the recommended reading level for consumer health information? 
2. Is the reading level for macular degeneration information above, at, or below 
this level? 
3. If the reading level of this information is above the recommended level, by how 
much is it above? 
 The objective of this study was to answer these questions in order to gain a better 
understanding of the accessibility of consumer health information online and see what 
changes would perhaps need to be made in regards to ease of understanding of the 
material.  
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II. Literature Review 
Macular degeneration is a condition of the eyes, which results in a partial or 
complete loss of central vision. This area of vision is damaged as significant amounts of 
drusen develop under the retinal pigment epithelium and neurosensory retina within the 
eye (Coleman et al. 1835). Drusen are composites consisting of protein, lipids, and cells 
(Stone 479). Age-related macular degeneration, or macular degeneration, is an umbrella 
term that actually consists of different forms of the disease that can be attributed to 
several different causes (Stone 478).  
 
Figure 1 – Anatomy of the Human Eye (unknown) 
In the past, it was believed that one single root cause of macular degeneration 
could be determined. However, this is not the case (Stone 479). Macular degeneration can 
be attributed to a number of various causes, or in some cases, a combination of them. 
Patients can live for years without adverse symptoms as the disease develops (Coleman et 
al. 1835).  
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One cause of macular degeneration for which there is no prevention is simply 
aging (Coleman et al. 1835). For some patients, genetics play a role in developing 
macular degeneration (Coleman et al. 1835). Genetics have the potential to be a 
contributing factor to increased risk of macular degeneration, and like aging, cannot be 
helped. Twin and family studies have been conducted to explore the role of genetics in 
the development of macular degeneration (Querques et al. 594). Medical science first 
discovered the link between heredity and macular degeneration in the late nineteenth 
century, before the term “genetics” was even widely used, as it was found that macular 
degeneration occurred within families (Stone 480-481). However, there isn’t one single 
gene in particular that increases an individual’s risk of developing macular degeneration 
(Stone 481). Instead, “high-risk alleles” occur across several locations within an 
individual’s DNA (Stone 481). While these genetic combinations do not inherently cause 
the development of macular degeneration, they do contribute to the likelihood of an 
individual developing the disease during their lifetime (Stone 481). Overall, genetics are 
the primary cause of approximately 23% of the cases of advanced macular degeneration 
(Coleman et al. 1838). 
Some causes of macular degeneration are entirely preventable, the most 
prominent of which is smoking (Coleman et al. 1835). There is a proven direct 
correlation between the quantity of cigarettes a patient smokes and the likelihood of 
suffering from advanced macular degeneration (Coleman et al. 1836). For smoker 
patients who have yet to develop macular degeneration, studies have shown that ceasing 
smoking can decrease the risk of macular degeneration (Stone 483).  
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A number of previous studies have supported an association between sun 
exposure and an increased risk of developing macular degeneration, but other studies 
have not supported this conclusion (Coleman et al. 1838). The degree to which sun 
exposure influences the development of macular degeneration remains inconclusive and 
needs to be explored in further research (Coleman et al. 1838). 
The effects of macular degeneration on a patient’s vision may vary depending on 
the type and severity of macular degeneration the patient has developed. Individuals can 
go years without symptoms, until they begin to complain of a combination of general 
vision loss, central vision loss, changes in color perception, and seeing grids of straight 
lines that appear wavy (Querques et al. 593). There are three stages of macular 
degeneration: early, intermediate, and advanced (Coleman et al. 1836).  
With early macular degeneration, drusen that have developed within the eye are 
small to medium sized, and the patient most likely has no noticeable symptoms (Coleman 
et al. 1836). Once macular degeneration advances to the intermediate level, drusen have 
become medium to large in size, and it is still possible that the patient hasn’t noticed any 
adverse symptoms of macular degeneration, such as vision loss (Coleman et al. 1836).   
During the advanced stages of macular degeneration, the condition can be 
characterized as one of two forms of the disease: as geographic, called “dry,” macular 
degeneration, or as neovascular, called “wet,” macular degeneration (Coleman et al. 
1836). With dry macular degeneration, areas of the retina have slowly lost their 
pigmentation and small blood vessels, resulting in the loss of central vision (Coleman et 
al. 1836). When a patient suffers from wet macular degeneration, fluids and blood leak as 
the sensory retina or retinal pigment epithelium detach (Coleman et al. 1836). Wet 
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macular degeneration is the most common form of macular degeneration (Coleman et al. 
1836). 
 
Figure 2 – Macular Degeneration (ADAM ) 
Macular degeneration is currently the most common cause of blindness in the 
developed world for individuals over fifty-five years of age of European descent 
(Coleman et al. 1835). Members of other racial and ethnic groups who are older than 
fifty-five do develop drusen in their lifetimes, but these individuals have a smaller chance 
of developing macular degeration than Caucasians (Coleman et al. 1836). Wet, or 
neovascular, macular degeneration is the most common cause of severe central vision 
loss among adults of this age group (Coleman et al. 1836). Smokers in general have a 
higher risk of developing macular degeneration than non-smokers regardless of race or 
ethnicity (Stone 478). In total, 10 – 15% of people with macular degeneration experience 
severe central vision loss (Querques et al. 593).  
Unfortunately, a cure for macular degeneration has yet to be discovered. This 
being the case, prevention and patient education are key to lessening the impact of 
macular degeneration on the adult population (Coleman et al. 1840). It is important to 
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empower patients to control what factors they can in lessening their risk of developing 
the disease, such as keeping a healthy body mass index and smoking cessation (Coleman 
et al. 1840). Previous studies have shown that these preventative measures taken by 
patients could reduce their chances of developing macular degeneration by half (Coleman 
et al. 1840).  
However, once a patient has developed macular degeneration, there are some 
treatments currently available to lessen the impact and progression of the disease. For 
patients at moderate risk of developing macular degeneration and who already have 
drusen developed within their eyes, taking regular supplements of zinc and antioxidant 
vitamins can reduce their risk of progressing into advanced macular degeneration by 
around 25% (Coleman et al. 1835). Taking supplements will not help all patients reduce 
their risk of developing advanced macular degeneration. It is important to note that this 
treatment should not be recommended to patients that smoke, as it will increase their risk 
of lung cancer (Coleman et al. 1840).  
Another form of treatment for macular degeneration involves a series of 
ranibizuamb injections into the affected eyes to slow and stop further vision loss 
(Coleman et al. 1835). For this treatment, the patient has injections on a monthly basis 
over a period of three months (Querques et al. 595). Ranibizuamb injections prevent 
further blood vessel growth as well as blood vessel leaks within the eye ("Ranibizumab 
Injection."). Because these injections work to counteract the leaking of blood vessels, 
they can only be used to treat wet macular degeneration and not dry macular 
degeneration. Current studies with this form of treatment suggest that it is a safe and 
effective way to improve and stabilize the vision of the patient (Querques et al. 594-595). 
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Patients undergoing this treatment will need to continue to visit their doctor for follow-up 
visits after they finish the series of ranibizuamb injections to ensure their vision is 
remaining stable and not worsening (Querques et al. 595). These injections are intended 
to stop further vision loss once a patient has already developed wet macular degeneration 
and are not a preventative treatment.  
An additional treatment for patients who have yet to develop advanced macular 
degeneration involves removing drusen within the eye with a special laser (Coleman et al. 
1841). Like ranibizuamb injections, this laser treatment is a management, not 
preventative, strategy for macular degeneration. Not all treatments are effective on all 
patients. Further research into treatments and cures for macular degeneration are 
currently underway. 
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III. Methods 
 For this research, eight consumer health information websites were chosen.  
These websites were selected based on a Google search and meeting a basic set of 
criteria. The Google search was for the term “macular degeneration.” Google was chosen 
as the search engine because it was the most frequently used search engine available (S. 
Kalarani and G. V. Uma 135). The search was performed and the list of results returned 
by Google was reviewed. The websites were required to meet three basic criteria: the 
owners of the websites must be based in the United States, the website’s primary 
audience was intended to be consumers, and the website must be credible. 
 For the purposes of this research, a website would be deemed credible based on 
Metzger’s basic definition of credibility: “credibility is a multifaceted concept with two 
primary dimensions: expertise and trustworthiness” (Metzger 2079). Each website within 
the study group of eight websites was required to be credible and display a high degree of 
expertise and trustworthiness.  
 After scrolling through the Google search results, exploring the websites it 
presented, and evaluating their credibility, eight websites were selected for this study. 
These websites were:  
• AARP’s Health page 
• BrightFocus Foundation 
• American Academy of Ophthalmology (eyeSmart) 
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• John Hopkins 
• Mayo Clinic  
• Medline Plus 
• National Eye Institute 
• WebMD.1  
Several of these websites are HONcode certified.  
 The HONcode is a certification system run by the HON Foundation for online 
consumer health information. It was the first established ethical evaluation system for 
websites providing health information to the public through the Internet ("HONcode: the 
commitment to reliable health and medical information on the internet."). Websites apply 
for certification and are evaluated based on a rigorous set of criteria outlined in eight 
principles: describing the credentials of content authors, a commitment to adding to 
instead of replacing visits to a qualified healthcare practitioner, confidentiality of website 
users, accurate citations, objectivity, transparency, financial disclosure, and clear 
advertising policies ("HONcode: the commitment to reliable health and medical 
information on the internet."). Once a website is certified to be HONcode compliant, it is 
periodically reviewed to ensure continued adherence to these eight principles 
("HONcode: the commitment to reliable health and medical information on the 
internet."). 
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WEBSITE 
HONcode 
Certified 
Government 
Sponsored 
Professional 
Association 
Hospital/ 
Clinic 
AARP Health Page x       
BrightFocus Foundation x       
eyeSmart     x   
John Hopkins       x 
Mayo Clinic x     x 
Medline Plus   x     
National Eye Institute   x     
WebMD x       
Table 1 – Website Credibility 
 
 For the purposes of this study, the text defining the condition of macular 
degeneration, the description of the disease, and treatment information were all analyzed. 
Text was taken during late January of 2013. The level of readability was determined 
using the Flesch-Kincaid Grade Level Index and the Flesch Reading Ease Score. The 
Flesch-Kincaid Grade Level Index test calculates the American grade level of written 
material (DuBay 26). It is one of the most popular reading ability calculators used today 
and is currently used by the Department of Defense, the Social Services Administration, 
and the Internal Revenue Service to calculate the readability of their published materials 
(DuBay 31, 54). The formula for calculating the grade level is: (0.39 x average sentence 
length) + (11.8 x average number of syllables per word) - 15.59, or GL = (0.39 x ASL) + 
(11.8 x ASW) - 15.59 (DuBay 54).  
The Flesch Reading Ease Score calculates the difficulty of reading material on a 
scale of one to one hundred, with a score of one hundred indicating a very easy level of 
readability, scores between sixty and seventy to be a “standard” reading level, and scores 
between zero and thirty to be at a college graduate level (DuBay 21-22). How the Flesch 
Reading Ease is calculated has changed since the test was invented, as the formula has 
been refined. The Flesch Reading Ease is currently calculated as: (1.599 x number of 
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one-syllable words per 100 words) – (1.015 x average sentence length in words) – 31.517 
(DuBay 22).  
The Flesch-Kincaid Grade Level Index and the Flesch Reading Ease Score were 
used to analyze the text from the eight websites by pasting the text into Microsoft Word 
for Mac 2011 and running the tests within the word processing program. Due to the 
limitations within Microsoft Word, the maximum grade level calculated for the Flesch-
Kincaid Grade Level Index is 12.0.  
                                                
NOTES 
1 See Appendix I for website urls and Appendix II for website screenshots. 
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IV. Website Information 
Each of the eight websites used for this study was reviewed for their consumer 
health information, specifically regarding macular degeneration definitions and treatment 
options. The information regarding each website, such as the owner and purpose behind 
the website, was obtained from the website itself. Some websites contained more of this 
background information than others.  
The Health page of the American Association of Retired Persons, or AARP, is 
owned and managed by AARP, which is a large nonprofit organization with over thirty-
seven million members ("About AARP.").  Dr. Ethel Percy Andrus founded AARP in 
1958 with the goal to “enhance the quality of life for older persons,” a goal to which the 
Health page contributes ("AARP History."). The health encyclopedia featured on the 
Health page is powered by Healthline, which is also a HONcode compliant website and is 
owned by Healthline Networks. Healthline exists to provide consumers with reliable 
health information for education and also so that patients may better communicate with 
their doctors ("Healthline.com's Mission Statement.").  
The BrightFocus Foundation, which was until very recently known as the 
American Health Assistance Foundation, was founded in 1973 ("About the BrightFocus 
Foundation."). As a nonprofit organization, the BrightFocus Foundation promotes 
research and public education for eye and brain diseases as they work “to save mind and 
sight” ("About the BrightFocus Foundation."). It is also a HONcode certified website. 
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eyeSmart is owned and maintained by the American Academy of Ophthalmology 
(AAO) and is geared towards everyday consumers of health information and promotes 
general public awareness of eye health and its importance ("About eyeSmart."). The 
American Academy of Ophthalmology is the largest national association of eye doctors 
and surgeons in the world ("About eyeSmart."). Through eyeSmart, the AAO educates 
patients about their personal risk factors for various eye diseases as well as other vision 
ailments and provides information about prevention, diagnosis, and treatment ("About 
eyeSmart."). eyeSmart has not been HONcode certified.  
Johns Hopkins Medicine is a nonprofit organization and is a system consisting of 
a hospital, clinics, and a medical school ("About Johns Hopkins Medicine."). Based in 
Baltimore, Maryland, Johns Hopkins continues to be one of the best hospitals in the 
country ("Johns Hopkins Medicine Fast Facts."). Their website is not HONcode certified. 
The Mayo Clinic is also a nonprofit organization and comprises a network of 
clinics located in Minnesota, Florida, and Arizona ("About Mayo Clinic."). The Mayo 
Clinic began as the practice of one physician, Dr. William Mayo, in 1863 and expanded 
as his two sons joined him ("History of Mayo Clinic."). Dr. William Mayo then took 
what was then a revolutionary step of asking researchers and other doctors to join them 
and thus created the first “private integrated group practice,” forever changing the 
practice of modern medicine ("History of Mayo Clinic."). The Mayo Clinic website is 
HONcode certified. 
MedlinePlus is a government website owned by the US National Institute of 
Health and produced by the US National Library of Medicine ("About MedlinePlus."). 
This website exists to provide reliable health information to patients and consumers and 
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is updated on a daily basis by the National Library of Medicine ("About MedlinePlus."). 
MedlinePlus is not HONcode certified.  
The National Eye Institute is also a government entity and is part of the National 
Institute of Health ("National Eye Institute Mission Statement."). The National Eye 
Institute was founded by the government in 1968 with the main purpose of conducting 
and advancing research of eye diseases and conditions in the United States ("National 
Eye Institute Mission Statement."). The National Eye Institute website is not HONcode 
certified.  
WebMD is a website owned by an organization of the same name. The goal of 
WebMD is to provide consumers accurate health information and reference materials as 
well as access to online health communities ("What We Do For Our Users."). It provides 
the general public in addition to healthcare professionals with current medical reference 
material that is accessible without a paid subscription("What We Do For Our Users."). 
WebMD has been designed to help people find current information on healthy living, 
diseases and conditions, and personal support("What We Do For Our Users."). The 
website is HONcode certified. 
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V. Results 
 After completing the analysis of the selected text of each website and calculating 
the Flesch-Kincaid Grade Level Index of each section of every website, the following 
results were discovered. The formula for calculating the grade level is: (0.39 x average 
sentence length) + (11.8 x average number of syllables per word) - 15.59 (DuBay 54).   
WEBSITE  
 
DEFINITION 
SECTION 
SCORE 
TREATMENT 
SECTION 
SCORE 
SCORE OF 
SECTIONS 
TAKEN 
TOGETHER 
TOTAL 
WORDS 
AARP's Health Page 11.9 11.1 11.5 107 
BrightFocus Foundation 12.0 12.0 12.0 350 
eyeSmart 12.0 12.0 12.0 1872 
Johns Hopkins 9.9 10.2 10.0 363 
Mayo Clinic 11.5 12.0 11.7 1092 
MedlinePlus 8.1 9.4 9.0 470 
National Eye Institute 6.9 7.8 7.5 450 
WebMD 10.9 11.6 11.2 735 
Table 2 – Flesch-Kincaid Grade Level Index Analysis Results 
 It was very clear that none of the information on the definition and treatments for 
macular degeneration for any of these websites was written at or below the recommended 
fifth grade level for health information or even the commonly recommended seventh 
grade level for general public information (DuBay 1). The information found on the 
National Eye Institute’s website came the closest to the recommended reading level for 
health information with a Flesch-Kincaid Grade Level Index of 7.5. The website with the 
next lowest grade level index was MedlinePlus, whose content scored a 9.0, followed by 
Johns Hopkins at 10.0. WebMD came next with a score of 11.2, closely followed by 
AARP’s Health page at 11.5 and Mayo Clinic’s score of 11.7. The final two websites, 
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BrightFocus Foundation and eyeSmart, both scored a 12.0 on the Flesch-Kincaid Grade 
Level Index. Taken as a group, the average Flesch-Kincaid Grade Level Index score for 
these websites is 10.6, nearly six grade levels above the recommended reading level for 
the health related material. Word count averaged at 680 words.  
 In order to gain further understanding of the readability of the material, the Flesch 
Reading Ease level of the text gathered from each website was also calculated. The 
Flesch Reading Ease is calculated as: (1.599 x number of one-syllable words per 100 
words) – (1.015 x average sentence length in words) – 31.517 (DuBay 22). 
WEBSITE 
FLESCH READING 
EASE SCORE 
AARP's Health Page 50.7 
BrightFocus Foundation 19.5 
eyeSmart 40.6 
Johns Hopkins 55.5 
Mayo Clinic 41.7 
MedlinePlus 55.6 
National Eye Institute 63.2 
WebMD 41.4 
Table 3 – Flesch Reading Ease Score Analysis Results 
 For the chosen websites and selected text on macular degeneration, the calculated 
range of Flesch Reading Ease scores varied from a low of 19.5 to a high of 63.2. The 
calculated average Flesch Reading ease score between all of the websites was 46.0. The 
website with the lowest Flesch Reading Ease score, indicating the most difficult text, was 
BrightFocus Foundation with a score of 19.5. The National Eye Institute had the simplest 
text and a score of 63.2. This was the only website that fell within the “standard” reading 
ease range of between sixty and seventy (DuBay 22). Below is a table which compares 
the Flesch-Kincaid Grade Level Index score, Flesch Reading Ease score, and total word 
count for each website.  
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WEBSITE 
FLESCH-KINCAID 
GRADE LEVEL 
INDEX 
FLESCH READING 
EASE SCORE 
TOTAL 
WORDS 
AARP's Health Page 11.5 50.7 107 
BrightFocus Foundation 12.0 19.5 350 
eyeSmart 12.0 40.6 1872 
Johns Hopkins 10.0 55.5 363 
Mayo Clinic 11.7 41.7 1092 
MedlinePlus 9.0 55.6 470 
National Eye Institute 7.5 63.2 450 
WebMD 11.2 41.4 735 
Table 4 – Flesch-Kincaid Grade Level Index and Flesch Reading Ease Score Results 
 
 As may be seen in the table above, websites with higher Flesch-Kincaid Grade 
Level scores have lower Flesch Reading Ease scores, indicating a lower level of 
readability due to more difficult text. Websites with lower Flesch-Kincaid Grade Level 
scores have higher Flesch Reading ease scores, indicating that the text is easier to read. It 
is interesting to note that both the BrightFocus Foundation and eyeSmart earned a score 
of 12.0 on the Flesch-Kincaid Grade Level index, but their Flesch Reading Ease scores 
differed by 21.1 points. eyeSmart had a much higher word count, but still earned a higher 
Flesch Reading Ease score, this indicating that eyeSmart’s information on macular 
degeneration is more difficult for readers to understand than BrightFocus Foundation’s 
text. Taking this information into account, it is very likely that both BrightFocus 
Foundation and eyeSmart scored the same 12.0 on the Flesch-Kincaid Grade Level Index 
and earned vastly different Flesch Reading Ease scores because the maximum score 
calculated for the Flesch-Kincaid Grade Level Index within Microsoft Word is 12.0.  
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VI. Limitations 
This study was conducted under a limited timeframe and without any additional 
monetary resources. All information was collected and analyzed within a three-month 
period due to the one semester length of the master’s paper course for which this paper 
was written. Had more time been allotted, the study could have included more websites 
for analysis. 
The Flesch-Kincaid Grade Level Index and the Flesch Reading Ease tests were 
chosen to evaluate the readability of the selected health information not only because 
they are widely used, but because they come included as a tool within Microsoft Word 
for Mac 2011 which had already been purchased. Free online readability calculators are 
available for a select few other tests, but the validity of the tools could not be determined. 
Software packages that can calculate the readability of text are commercially available 
but were deemed too costly.  
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VII. Conclusion 
Calculations using both the Flesch-Kincaid Grade Level Index and the Flesch 
Reading Ease confirmed expectations that online consumer health information for 
macular degeneration is written at a reading level that makes it incomprehensible for a 
sizeable portion of the American population. According to the National Adult Literacy 
Survey, nearly half of Americans have a reading comprehension level below the sixth 
grade (DuBay 1).  It is recommended that consumer health information maintain a 
reading level at or below the fifth grade, yet the lowest calculated Flesch-Kincaid Grade 
Level Index score for these eight websites’ information on macular degeneration was 7.5, 
a full two and a half grades above the recommended level for the material.  
Websites and their owners need to be made aware that their consumer health 
information is difficult for many of their users to understand. It is recommended that 
content be rewritten in order to reach a broader audience. As an increasing number of 
Americans phase into the age demographic most affected by macular degeneration, it is 
critically important to ensure that as many people as possible can easily read and 
understand the information they find about the disease on reliable Internet websites.  
Further research on this topic employing a larger sample of websites and 
analyzing the content written for diseases other than macular degeneration may be a 
useful addition to the consumer health information literature. Additional research could 
also use other readability evaluations in addition to the Flesch-Kincaid Grade Level Index 
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and the Flesch Reading Ease Score in order to compare the results of different readability 
evaluation methods.  
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Appendix I 
Website Links 
 
AARP's Health Page www.aarp.org/health 
BrightFocus Foundation www.brightfocus.org 
eyeSmart www.geteyesmart.org  
JohnsHopkins www.hopkinsmedicine.org/ 
Mayo Clinic www.mayoclinic.com 
MedlinePlus www.nlm.nih.gov/medlineplus 
National Eye Institute www.nei.nih.gov 
WebMD http://www.webmd.com  
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Appendix II 
Website Screenshots 
 
 
AARP’s Health page 
 
 28 
 
Bright Foucs Foundation 
 
 
eyeSmart 
 
 29 
 
Johns Hopkins 
 
 
Mayo Clinic – Dry Macular Degeneration 
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Mayo Clinic – Wet Macular Degeneration 
 
 
MedlinePlus 
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National Eye Institute 
 
 
WebMD 
 
